FDA Approves Elotuzumab, Pomalidomide, Dexamethasone for Multiple Myeloma
FDA Approves Second Biosimilar to Neulasta
CMS Releases CY 2019 OPPS Rule
CMS Releases 2019 PFS and QPP Final Rule
FDA Approves Pembrolizumab for First-Line Treatment of Metastatic Squamous NSCLC
ACCC Statement in Response to Administration’s Part B Drug Pricing ANPRM
FDA Approves Levoleucovorin for Injection for mCRC, Osteosarcoma
HHS Secretary Azar Provides Updates to Drug Pricing Blueprint
FDA Approves Talazoparib for gBRCAm HER2- Breast Cancer
New Clinical Guideline Issued for Early-Stage Prostate Cancer Patients Treated with EBRT
CMS Acts to Support Georgia in Response to Hurricane Michael
CMS Announces Steps to Support Florida in Response to Hurricane Michael
NCCN Releases New Guidelines for Neuroendocrine Tumors
FDA Expands Approval of HPV Vaccine to People Aged 27 to 45
MedPAC Suggests Expansion of DVP to Inpatient Setting
Nobel Prize in Medicine Awarded to Two Cancer Immunotherapy Researchers
HHS OIG Report Raises Concerns About Medicare Advantage Step Therapy
FDA Approves NGS Test to Detect MRD in ALL and Myeloma
FDA Approves Cemiplimab-rwlc for Cutaneous Squamous Cell Carcinoma
FDA Approves Dacomitinib for Metastatic NSCLC
House Approves Legislation Banning Pharmacist “Gag Clauses”
FDA Approves Duvelisib for CLL/SLL, FL
ACCC Submits Comments to Proposed 2019 OPPS Rule
Pfizer Announces Relief for Cancer Patients Affected by Hurricane Florence
Hogan Lovells to Host Webinar on Legal Considerations of Telehealth
CMS Issues CY 2019 Proposed Rule Aimed at Efficiency, Transparency, Clinician Burden
House of Representatives Passes Transparency Reforms to Medicare LCDs
FDA Approves New Treatment for Hairy Cell Leukemia
CMS Supports North Carolina and South Carolina Ahead of Hurricane Florence
AACR Releases Annual Cancer Progress Report
